av/fresenius-medical-care--big.svg

COM:FRESENIUSMEDICALCARE

Fresenius Medical Care

  • Stock

EUR

Last Close

42.25

25/11 09:24

Market Cap

10.62B

Beta: -

Volume Today

26.51K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
855.94M
-
1.07B
25.23%
1.28B
19.74%
1.32B
2.51%
1.38B
4.80%
1.57B
13.51%
1.78B
13.69%
1.97B
10.53%
2.17B
10.19%
2.24B
3.26%
average payables
534.89M
-
650.65M
21.64%
777.88M
19.55%
789.69M
1.52%
766.45M
2.94%
815.12M
6.35%
831.29M
1.98%
842.46M
1.34%
894.43M
6.17%
908.24M
1.54%
average receivables
2.98B
-
3.56B
19.37%
3.97B
11.63%
3.92B
1.32%
3.73B
4.88%
3.87B
3.66%
3.79B
1.89%
3.76B
0.82%
3.97B
5.48%
4.05B
1.94%
book value per share
27.28
-
31.53
15.61%
35.63
12.99%
35.32
0.87%
42.09
19.16%
43.70
3.82%
41.93
4.04%
47.72
13.79%
52.68
10.40%
capex per share
-5.04
-
-5.67
12.60%
-6.35
11.95%
-5.82
8.31%
-6.72
15.41%
-7.39
10.02%
-7.10
3.96%
-5.75
19.09%
-4.81
16.25%
capex to depreciation
-2.65
-
-2.63
0.62%
-2.63
0.06%
-2.43
7.95%
-2.84
17.16%
-1.40
50.56%
-1.17
16.78%
-1.04
11.34%
-0.77
25.95%
-0.39
49.09%
capex to operating cash flow
-1.00
-
-0.96
3.21%
-0.95
0.94%
-0.81
14.66%
-1.00
22.68%
-0.87
12.73%
-0.49
43.42%
-0.68
37.08%
-0.65
3.70%
-0.26
60.00%
capex to revenue
-0.12
-
-0.11
3.57%
-0.11
1.07%
-0.10
11.96%
-0.12
24.03%
-0.13
2.86%
-0.12
8.70%
-0.10
18.30%
-0.07
23.85%
-0.04
51.62%
cash per share
2.18
-
2.47
13.15%
3.15
27.46%
3.20
1.77%
7.33
128.81%
3.77
48.54%
4.23
12.15%
5.52
30.64%
4.92
10.86%
days of inventory on hand
37.58
-
42.90
14.17%
42.42
1.12%
39.99
5.72%
47.00
17.51%
50.25
6.93%
56.14
11.72%
59.31
5.64%
59.49
0.31%
54.75
7.98%
days payables outstanding
24.05
-
24.99
3.90%
26.63
6.58%
22.86
14.15%
25.47
11.42%
25.23
0.94%
24.51
2.87%
24.96
1.82%
24.13
3.31%
22.24
7.84%
days sales outstanding
93.08
-
90.63
2.63%
88.91
1.90%
75.87
14.67%
83.06
9.48%
82.90
0.20%
73.97
10.77%
80.93
9.42%
75.86
6.27%
76.19
0.43%
debt to assets
0.37
-
0.34
9.60%
0.32
6.02%
0.31
2.59%
0.29
7.24%
0.42
45.52%
0.39
6.64%
0.39
0.79%
0.37
4.65%
0.36
3.89%
debt to equity
0.95
-
0.82
13.34%
0.75
9.18%
0.69
8.06%
0.58
14.96%
1.04
78.15%
1.00
3.65%
0.95
5.09%
0.86
10.24%
0.88
3.45%
dividend yield
0.01
-
0.01
27.22%
0.01
5.30%
0.01
2.94%
0.02
67.85%
0.02
4.05%
0.02
1.42%
0.02
33.89%
0.04
88.20%
earnings yield
0.05
-
0.04
13.46%
0.05
20.81%
0.05
0.05%
0.11
135.20%
0.06
46.79%
0.06
3.43%
0.06
0.26%
0.08
29.68%
enterprise value
26.02B
-
31.07B
19.42%
32.04B
3.11%
33.12B
3.39%
22.95B
30.72%
32.74B
42.68%
31.35B
4.24%
28.58B
8.85%
20.90B
26.85%
10.65B
49.07%
enterprise value over ebitda
10.42
-
10.75
3.16%
9.74
9.38%
10.55
8.29%
7.40
29.83%
14.22
92.12%
13.54
4.73%
14.85
9.61%
13.23
10.88%
3.10
76.60%
ev to operating cash flow
17.00
-
17.33
1.95%
15.74
9.15%
15.11
4.03%
11.13
26.35%
12.75
14.61%
7.41
41.93%
11.48
55.01%
9.65
15.98%
4.05
58.01%
ev to sales
2.00
-
2.03
1.56%
1.88
7.31%
1.86
0.99%
1.39
25.54%
1.87
35.09%
1.76
6.29%
1.62
7.61%
1.08
33.56%
0.55
49.21%
free cash flow per share
0.02
-
0.22
783.65%
0.30
40.89%
1.33
335.62%
0.01
99.51%
1.09
16,559.25%
7.29
571.12%
2.75
62.28%
2.58
6.30%
free cash flow yield
0.00
-
0.00
603.12%
0.00
36.13%
0.02
303.10%
0.00
99.25%
0.02
14,356.87%
0.11
549.08%
0.05
54.98%
0.08
75.14%
graham net net
-30.01
-
-31.33
4.42%
-32.62
4.11%
-28.70
12.02%
-24.59
14.33%
-48.76
98.31%
-49.15
0.81%
-50.59
2.94%
-50.09
0.99%
graham number
41.77
-
46.83
12.14%
55.67
18.86%
57.60
3.48%
78.25
35.84%
62.43
20.21%
61.11
2.11%
59.59
2.49%
52.16
12.48%
income quality
1.48
-
1.49
1.07%
1.38
7.45%
1.41
2.10%
0.93
34.33%
1.78
92.58%
2.95
65.36%
2.04
30.78%
2.42
18.58%
5.27
117.58%
intangibles to total assets
0.55
-
0.54
0.97%
0.54
0.75%
0.53
1.23%
0.49
7.70%
0.47
4.54%
0.45
3.50%
0.46
1.73%
0.48
5.17%
0.47
2.52%
interest coverage
4.56
-
4.58
0.55%
5.82
27.13%
5.95
2.17%
6.78
13.98%
1.45
78.68%
1.29
10.77%
0.85
33.84%
-0.72
184.08%
4.46
720.80%
interest debt per share
27.27
-
27.50
0.84%
28.07
2.05%
25.59
8.82%
26.08
1.91%
47.16
80.82%
43.50
7.76%
46.67
7.31%
46.28
0.84%
inventory turnover
9.71
-
8.51
12.41%
8.60
1.14%
9.13
6.06%
7.77
14.90%
7.26
6.48%
6.50
10.49%
6.15
5.34%
6.14
0.30%
6.67
8.67%
invested capital
0.95
-
0.82
13.34%
0.75
9.18%
0.69
8.06%
0.58
14.96%
1.04
78.15%
1.00
3.65%
0.95
5.09%
0.86
10.24%
0.88
3.45%
market cap
18.70B
-
23.66B
26.55%
24.60B
3.94%
26.65B
8.36%
17.55B
34.17%
19.97B
13.79%
20.05B
0.45%
16.74B
16.53%
8.96B
46.44%
net current asset value
-7.15B
-
-7.37B
3.02%
-7.76B
5.38%
-6.82B
12.09%
-5.49B
19.49%
-12.54B
128.35%
-12.08B
3.67%
-12.42B
2.80%
-12.10B
2.57%
-10.40B
14.05%
net debt to ebitda
2.93
-
2.56
12.57%
2.26
11.71%
2.06
8.92%
1.74
15.45%
5.55
218.53%
4.88
12.01%
6.15
26.01%
7.56
22.87%
3.10
59.02%
net income per share
2.84
-
3.09
8.77%
3.87
25.04%
4.18
8.01%
6.47
54.85%
3.96
38.68%
3.96
0.15%
3.31
16.44%
2.29
30.62%
operating cash flow per share
5.06
-
5.89
16.33%
6.66
13.02%
7.15
7.44%
6.73
5.92%
8.48
26.07%
14.40
69.74%
8.50
40.98%
7.39
13.03%
payables turnover
15.18
-
14.61
3.75%
13.71
6.17%
15.97
16.48%
14.33
10.25%
14.46
0.95%
14.89
2.96%
14.63
1.79%
15.13
3.42%
16.41
8.51%
receivables turnover
3.92
-
4.03
2.70%
4.11
1.93%
4.81
17.20%
4.39
8.66%
4.40
0.20%
4.93
12.07%
4.51
8.61%
4.81
6.69%
4.79
0.43%
research and ddevelopement to revenue
0.01
-
0.01
8.54%
0.01
8.14%
0.01
18.56%
0.01
9.94%
0.01
18.70%
0.01
13.01%
0.01
15.47%
0.01
5.88%
0.01
1.02%
return on tangible assets
0.09
-
0.09
3.00%
0.10
13.50%
0.11
13.81%
0.15
30.34%
0.07
53.79%
0.07
2.21%
0.05
22.13%
0.04
30.16%
0.03
23.68%
revenue per share
43.06
-
50.29
16.78%
55.70
10.76%
58.01
4.15%
53.98
6.95%
57.74
6.96%
60.73
5.19%
60.14
0.97%
66.15
9.98%
roe
0.10
-
0.10
5.92%
0.11
10.66%
0.12
8.96%
0.15
29.95%
0.09
40.94%
0.09
4.05%
0.07
26.57%
0.04
37.16%
0.04
15.90%
roic
0.08
-
0.08
4.66%
0.09
10.87%
0.10
9.42%
0.12
20.81%
0.02
85.52%
0.02
11.50%
0.01
52.92%
-0.01
177.97%
0.03
691.36%
sales general and administrative to revenue
shareholders equity per share
27.28
-
31.53
15.61%
35.63
12.99%
35.32
0.87%
42.09
19.16%
43.70
3.82%
41.93
4.04%
47.72
13.79%
52.68
10.40%
stock based compensation to revenue
0.00
-
0.00
37.02%
0.00
128.84%
0.00
56.23%
0.00
75.33%
0.00
82.45%
-0.11
93,299.06%
-0.10
9.65%
0.02
-
tangible asset value
-3.23B
-
-3.08B
4.54%
-2.91B
5.62%
-1.96B
32.60%
11M
100.56%
-2.22B
20,254.55%
-2.01B
9.38%
-1.84B
8.31%
-1.86B
1.03%
-1.19B
36.28%
tangible book value per share
-10.67
-
-10.12
5.21%
-9.51
6.04%
-6.39
32.78%
0.04
100.56%
-7.32
20,390.88%
-6.83
6.72%
-6.29
7.95%
-6.35
0.92%
working capital
2.67B
-
2.56B
4.17%
2.16B
15.42%
1.07B
50.38%
1.58B
46.98%
157.77M
90.01%
1.11B
606.74%
709M
36.41%
1.74B
144.85%
2.59B
49.18%

All numbers in EUR (except ratios and percentages)